Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Bladder Cancer
Related studies linked through entity extraction aliases.
A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology
- Status
- RECRUITING
- Phase
- N/A
Effect of Tumor Base Size in Bladder Cancer
- Status
- COMPLETED
- Phase
- NA
Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)
- Status
- RECRUITING
- Phase
- PHASE2
Study on the Staging and Prognosis Model of Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC)
- Status
- RECRUITING
- Phase
- PHASE1
The Impact of PDD During TURB for NMIBC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Physical Activity, Kinesiophobia, and Stoma Compliance in Urostomy Patients
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers
- Status
- RECRUITING
- Phase
- NA
Telehealth Intervention for Ostomy Self-Management
- Status
- RECRUITING
- Phase
- PHASE2
Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
- Status
- RECRUITING
- Phase
- PHASE3
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- Status
- RECRUITING
- Phase
- PHASE2
Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria
- Status
- NOT_YET_RECRUITING
- Phase
- N/A